Literature DB >> 9619812

Determinants of delayed diagnosis of HIV infection in France, 1993-1995.

E Couturier1, V Schwoebel, C Michon, J B Hubert, M C Delmas, P Morlat, F Boué, A M Simonpoli, F Dabis, J B Brunet.   

Abstract

OBJECTIVE: To describe the circumstances of the first HIV-positive test and to study the determinants of a delayed diagnosis of HIV infection.
METHODS: In a retrospective study among adult AIDS patients diagnosed between July 1993 and May 1995 in two French districts, data on socioeconomic characteristics, circumstances of first HIV-positive test and attitudes and behaviours regarding medical care were collected in a confidential interview and analysed for potential association with a late test, defined as a first HIV-positive test within 6 months of AIDS diagnosis.
RESULTS: Of the 359 AIDS patients studied, 69 (19.2%) had a late test. Late testers were more likely than other patients to have had an HIV-positive test because of clinical symptoms (89.7 versus 38.9%, P < 0.001) and not to perceive themselves as being at risk of infection with HIV (53.6 versus 39.3%, P < 0.05). The proportion of late testers was 34.6% among heterosexually infected patients, 12.7% among homo-/ bisexual men and 9.6% among injecting drug users. Factors independently associated with a late test were male gender [adjusted odds ratio (aOR), 5.6; 95% confidence interval (CI), 1.7-18.9] and absence of earned income (aOR, 5.2; 95% CI, 1.4-19) among heterosexually infected patients; high education (aOR, 3.1; 95% CI, 1.0-9.6) and having consulted a person practising alternative medicine (aOR, 3.4; 95% CI, 1.2-10) in homo-/bisexual men.
CONCLUSIONS: Despite incentives to be tested for HIV, many individuals in France are still tested too late, even if they are in known high-risk groups. Efforts to test HIV-infected people as early as possible should be made by increasing the perception of HIV risk and decreasing the level of missed opportunities for testing. Current case management approaches make this recommendation critically important from both public health and an individual perspective.

Entities:  

Mesh:

Year:  1998        PMID: 9619812     DOI: 10.1097/00002030-199807000-00016

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  14 in total

1.  Declining incidence of AIDS and increasing prevalence of AIDS presenters among AIDS patients in Italy.

Authors:  B Castelnuovo; E Chiesa; S Rusconi; F Adorni; M Bongiovanni; S Melzi; P Cicconi; F Tordato; L Meroni; T Bini; A d'Arminio Monforte
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-10-21       Impact factor: 3.267

2.  Late presenters to HIV care and treatment, identification of associated risk factors in HIV-1 infected Indian population.

Authors:  Kamalika Mojumdar; Madhu Vajpayee; Neeraj K Chauhan; Sanjay Mendiratta
Journal:  BMC Public Health       Date:  2010-07-13       Impact factor: 3.295

3.  'Slipping through the cracks': policy implications of delays in HIV treatment seeking.

Authors:  Janet W McGrath; David Kaawa-Mafigiri; Sarah Bridges; Nelson Kakande
Journal:  Glob Public Health       Date:  2012-07-19

4.  Determinants and prevalence of late HIV testing in Tijuana, Mexico.

Authors:  Claudia M Carrizosa; Elaine J Blumberg; Melbourne F Hovell; Ana P Martinez-Donate; Gregorio Garcia-Gonzalez; Remedios Lozada; Norma J Kelley; C Richard Hofstetter; Carol L Sipan
Journal:  AIDS Patient Care STDS       Date:  2010-05       Impact factor: 5.078

5.  Late HIV Testing in a Cohort of HIV-Infected Patients in Puerto Rico.

Authors:  Katherine Y Tossas-Milligan; Robert F Hunter-Mellado; Angel M Mayor; Diana M Fernández-Santos; Mark S Dworkin
Journal:  P R Health Sci J       Date:  2015-09       Impact factor: 0.705

6.  Rapid HIV testing for individuals on probation/parole: outcomes of an intervention trial.

Authors:  Michael S Gordon; Timothy W Kinlock; Michelle McKenzie; Monique E Wilson; Josiah D Rich
Journal:  AIDS Behav       Date:  2013-07

7.  Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa.

Authors:  Isaac M Kigozi; Loren M Dobkin; Jeffrey N Martin; Elvin H Geng; Winnie Muyindike; Nneka I Emenyonu; David R Bangsberg; Judith A Hahn
Journal:  J Acquir Immune Defic Syndr       Date:  2009-10-01       Impact factor: 3.731

8.  Factors associated with presentation to care with advanced HIV disease in Brussels and Northern France: 1997-2007.

Authors:  Bakhao Ndiaye; Julia Salleron; Anne Vincent; Pierre Bataille; Frédérique Bonnevie; Philippe Choisy; Karine Cochonat; Clotilde Fontier; Habib Guerroumi; Bernard Vandercam; Hugues Melliez; Yazdan Yazdanpanah
Journal:  BMC Infect Dis       Date:  2011-01-12       Impact factor: 3.090

9.  Comparing Measures of Late HIV Diagnosis in Washington State.

Authors:  Laura Saganic; Jason Carr; Rosa Solorio; Maria Courogen; Tom Jaenicke; Ann Duerr
Journal:  AIDS Res Treat       Date:  2011-11-15

10.  Late HIV diagnosis and determinants of progression to AIDS or death after HIV diagnosis among injection drug users, 33 US States, 1996-2004.

Authors:  Anna Grigoryan; H Irene Hall; Tonji Durant; Xiangming Wei
Journal:  PLoS One       Date:  2009-02-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.